// App-Quantinova.ai

PB0007 : Post-partum Acquired Haemophilia A in the COVID era – building the case for Emicizumab?

Researchers

Presenter

  • C. Crossette-Thambiah

Principal Investigators

  • D. Arachchillage

  • M. Laffan

Medical Centers

  • NCRI and Imperial College London, London, United Kingdom

  • Department of Immunology and Inflammation, Imperial College London, London, England, United Kingdom

  • Centre for Haematology, Imperial Collegel, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Hemophilia

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Oraprine

  • Rituximab

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved